Xu, Jian-Fang <br/><br/>
[Gefitinib in the treatment of refractory non-small cell lung cancer].  [electronic resource] 

 -  Zhonghua zhong liu za zhi [Chinese journal of oncology]  Dec 2007 
 - 938-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0253-3766 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--adverse effects<br/>Bone Neoplasms--secondary<br/>Brain Neoplasms--secondary<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Diarrhea--chemically induced<br/>Disease-Free Survival<br/>ErbB Receptors--antagonists & inhibitors<br/>Exanthema--chemically induced<br/>Female<br/>Follow-Up Studies<br/>Gefitinib<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Quality of Life<br/>Quinazolines--adverse effects<br/>Remission Induction<br/>Survival Rate